Consumption of Fixed Capital in Noise and Vibration Abatement in Manufacture of Basic Pharmaceutical Products and Pharmaceutical Preparations

This key economic indicator for the Pharmaceutical sector has been recently updated.

  1. In 2016, Consumption of Fixed Capital in Noise and Vibration Abatement in Manufacture of Basic Pharmaceutical Products and Pharmaceutical Preparations in Belgium remained stable from a year earlier.
  2. Since 2013 Germany Consumption of Fixed Capital in Noise and Vibration Abatement in Manufacture of Basic Pharmaceutical Products and Pharmaceutical Preparations showed no change close to €0.1 Million.
  3. In 2016 Belgium was ranked number 1 in Consumption of Fixed Capital in Noise and Vibration Abatement in Manufacture of Basic Pharmaceutical Products and Pharmaceutical Preparations to €0.1 Million, from 1 in 2015.

Top Countries in Consumption of Fixed Capital in Noise and Vibration Abatement in Manufacture of Basic Pharmaceutical Products and Pharmaceutical Preparations

Million Euros - 2013 to 2016

# 2 Countries Million Euros Last YoY 5‑years CAGR
1 #1
Belgium
0.10 2016 +0.0 % NA View data
1 #1
Germany
0.10 2016 +0.0 % +0.0 % View data

Source: OECD

Go Top